Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis-Reference-Cited by-同舟云学术

Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis

Published:2015-10-05 Issue:11 Volume:125 Page:4107-4121
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Millet Arnaud,Martin Katherine R.,Bonnefoy Francis,Saas Philippe,Mocek Julie,Alkan Manal,Terrier Benjamin,Kerstein Anja,Tamassia Nicola,Satyanarayanan Senthil Kumaran,Ariel Amiram,Ribeil Jean-Antoine,Guillevin Loïc,Cassatella Marco A.,Mueller Antje,Thieblemont Nathalie,Lamprecht Peter,Mouthon Luc,Perruche Sylvain,Witko-Sarsat Véronique

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference84 articles.

1. Pathogenesis of Antineutrophil Cytoplasmic Autoantibody–Associated Small-Vessel Vasculitis

2. Genetically Distinct Subsets within ANCA-Associated Vasculitis

3. Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells

4. Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils.

5. Cleavage of p21/WAF1/CIP1 by Proteinase 3 Modulates Differentiation of a Monocytic Cell Line

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Granulomatosis with polyangiitis with and without antineutrophil cytoplasmic antibodies: a case-control study;Rheumatology;2024-07-27

2. Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis;Journal of Advanced Research;2024-07

3. Pathogenesis of Pulmonary Manifestations in ANCA-Associated Vasculitis and Goodpasture Syndrome;International Journal of Molecular Sciences;2024-05-12

4. Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis;The Lancet Rheumatology;2024-05

5. In situ neutrophil apoptosis and macrophage efferocytosis mediated by Glycyrrhiza protein nanoparticles for acute inflammation therapy;Journal of Controlled Release;2024-05